Euda Health Holdings Stock Alpha and Beta Analysis
| EUDA Stock | 3.75 0.12 3.31% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as EUDA Health Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in EUDA Health over a specified time horizon. Remember, high EUDA Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to EUDA Health's market risk premium analysis include:
Beta (0.53) | Alpha (0.10) | Risk 5.23 | Sharpe Ratio (0.1) | Expected Return (0.51) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
EUDA |
EUDA Health Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. EUDA Health market risk premium is the additional return an investor will receive from holding EUDA Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in EUDA Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate EUDA Health's performance over market.| α | -0.1 | β | -0.53 |
EUDA Health expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of EUDA Health's Buy-and-hold return. Our buy-and-hold chart shows how EUDA Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.EUDA Health Market Price Analysis
Market price analysis indicators help investors to evaluate how EUDA Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading EUDA Health shares will generate the highest return on investment. By understating and applying EUDA Health stock market price indicators, traders can identify EUDA Health position entry and exit signals to maximize returns.
EUDA Health Return and Market Media
The median price of EUDA Health for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 4.07 with a coefficient of variation of 14.68. The daily time series for the period is distributed with a sample standard deviation of 0.61, arithmetic mean of 4.19, and mean deviation of 0.46. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance ... | 12/16/2024 |
2 | EUDA Health Holdings Limited Short Interest Up 33.6 percent in January - MarketBeat | 02/03/2025 |
3 | Disposition of tradable shares by Liew Kwong Yeow of EUDA Health subject to Rule 16b-3 | 02/07/2025 |
4 | EUDA Health Holdings Limited Short Interest Update - MarketBeat | 02/20/2025 |
About EUDA Health Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including EUDA or other stocks. Alpha measures the amount that position in EUDA Health Holdings has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 (projected) | Interest Debt Per Share | 0.33 | 0.12 | 0.11 | Revenue Per Share | 0.82 | 0.14 | 0.16 |
EUDA Health Upcoming Company Events
As portrayed in its financial statements, the presentation of EUDA Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, EUDA Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of EUDA Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of EUDA Health. Please utilize our Beneish M Score to check the likelihood of EUDA Health's management manipulating its earnings.
| 30th of October 2023 Upcoming Quarterly Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View |
Build Portfolio with EUDA Health
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out EUDA Health Backtesting, EUDA Health Valuation, EUDA Health Correlation, EUDA Health Hype Analysis, EUDA Health Volatility, EUDA Health History and analyze EUDA Health Performance. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
EUDA Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.